Mills KI - Search Results

1

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia.

Guinn BA, Gilkes AF, Mufti GJ, Burnett AK, Mills KI. Guinn BA, et al. Among authors: mills ki. Br J Haematol. 2006 Jul;134(2):238-9. doi: 10.1111/j.1365-2141.2006.06135.x. Br J Haematol. 2006. PMID: 16846483 Free article. No abstract available.

2

Comparison of the survival implications of tumour-associated versus cancer-testis antigen expression in acute myeloid leukaemia.

Guinn BA, Tobal K, Mills KI. Guinn BA, et al. Among authors: mills ki. Br J Haematol. 2007 Feb;136(3):510-2. doi: 10.1111/j.1365-2141.2006.06454.x. Br J Haematol. 2007. PMID: 17278264 Free article. No abstract available.

3

FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.

Walsby EJ, Gilkes AF, Tonks A, Darley RL, Mills KI. Walsby EJ, et al. Among authors: mills ki. Br J Haematol. 2007 Oct;139(1):94-7. doi: 10.1111/j.1365-2141.2007.06756.x. Br J Haematol. 2007. PMID: 17854312 Free article.

4

Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.

Al Shaer L, Walsby E, Gilkes A, Tonks A, Walsh V, Mills K, Burnett A, Rowntree C. Al Shaer L, et al. Br J Haematol. 2008 May;141(4):483-93. doi: 10.1111/j.1365-2141.2008.07053.x. Epub 2008 Mar 27. Br J Haematol. 2008. PMID: 18373709 Free article.

5

Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.

Jenkins C, Hewamana S, Gilkes A, Neelakantan S, Crooks P, Mills K, Pepper C, Burnett A. Jenkins C, et al. Br J Haematol. 2008 Dec;143(5):661-71. doi: 10.1111/j.1365-2141.2008.07392.x. Br J Haematol. 2008. PMID: 19036014 Free article.

6

Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.

Guinn BA, Gilkes AF, Woodward E, Westwood NB, Mufti GJ, Linch D, Burnett AK, Mills KI. Guinn BA, et al. Among authors: mills ki. Biochem Biophys Res Commun. 2005 Aug 5;333(3):703-13. doi: 10.1016/j.bbrc.2005.05.161. Biochem Biophys Res Commun. 2005. PMID: 15963951

7

Rapid and sensitive detection of internal tandem duplication and activating loop mutations of FLT3.

Mills KI, Gilkes AF, Walsh V, Sweeney M, Gale R. Mills KI, et al. Br J Haematol. 2005 Jul;130(2):203-8. doi: 10.1111/j.1365-2141.2005.05589.x. Br J Haematol. 2005. PMID: 16029448 Free article.

8

SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients.

Guinn BA, Bullinger L, Thomas NS, Mills KI, Greiner J. Guinn BA, et al. Among authors: mills ki. Br J Haematol. 2008 Jan;140(2):250-1. doi: 10.1111/j.1365-2141.2007.06892.x. Epub 2007 Nov 19. Br J Haematol. 2008. PMID: 18028484 Free article. No abstract available.

9

Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia.

McLornan D, Hay J, McLaughlin K, Holohan C, Burnett AK, Hills RK, Johnston PG, Mills KI, McMullin MF, Longley DB, Gilkes A. McLornan D, et al. Among authors: mills ki. Br J Haematol. 2013 Jan;160(2):188-98. doi: 10.1111/bjh.12108. Epub 2012 Nov 20. Br J Haematol. 2013. PMID: 23167276 Free article.

10

High FUS/TLS expression in acute myeloid leukaemia samples.

Mills KI, Walsh V, Gilkes AF, Sweeney MC, Mirza T, Woodgate LJ, Brown G, Burnett AK. Mills KI, et al. Br J Haematol. 2000 Feb;108(2):316-21. doi: 10.1046/j.1365-2141.2000.01883.x. Br J Haematol. 2000. PMID: 10691862 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page